CSI Market
Sign In | Register

Moonlake Immunotherapeutics (MLTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MLTX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Moonlake Immunotherapeutics's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MLTX/balance-sheets
https://api.csimarket.com/api/v1/companies/MLTX/fundamentals
https://api.csimarket.com/api/v1/companies/MLTX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent379.70
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments379.00
Other Receivables, Net, Current0.00
Other Current Assets0.00
Prepaid Expense, Current AS25.93
Total Current Assets533.34
Equipment/Property/Plant Net0.44
Long-term investments2.98
Prepaid Expense, Noncurrent, Total PR1.35
Other Assets, Noncurrent130.31
Operating Lease Right Of Use Asset1.86
Total Assets540.72
Liabilities
Accrued Liabilities And Other Liabilities3.82
Other Liabilities, Current53.92
Taxes Payable0.68
Total Current Liabilities58.43
Long-term debt100.01
Total Long-term Debt100.01
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.00
Other liabilities, Noncurrent0.65
Operating Lease Liability Current0.92
Operating Lease Liability Noncurrent0.87
Total Liabilities159.09
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,053.30
Retained Earnings / Accumulated Deficit-673.97
Accumulated Other Comprehensive Income2.29
Other Equity2.29
Common Stockholder's Equity381.63
Non-controlling interests & other0.00
Total Stockholder's Equity381.63
Liabilities & Stockholder's Equity540.72
4 historic quarters locked

Sign in to unlock the full Moonlake Immunotherapeutics balance sheet history.

Sign In Create Free Account

About Moonlake Immunotherapeutics Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001821586-26-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI